Last reviewed · How we verify

NCT05397509: OLIFTEA

Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA)

Status unknown NA Last updated 31 May 2022
What this trial tests

NA trial testing Olive leaf tea in Blood Glucose in 20 participants. Status unknown.

Timeline
29 April 2022
Primary endpoint
30 June 2022
30 June 2022

Quick facts

Lead sponsorInstituto Politécnico de Bragança
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposeprevention
Enrollment20
Start date29 April 2022
Primary completion30 June 2022
Estimated completion30 June 2022
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Politécnico de Bragança

Who can join

Adults 18 to 60, any sex, with Blood Glucose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study tests the effect of Olive Tea Ingestion in ameliorating glycemic response after a high-glycemic meal

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Olive Leaf Tea Impact on Postprandial Glycemia: A Randomized Cross-Over Trial.
    Meireles M, Cortez-Ribeiro AC, Polck D, Almeida-de-Souza J, et al · · 2023 · cited 2× · PMID 36766057 · DOI 10.3390/foods12030528

Verify or expand the search:

Other trials of Olive leaf tea

Trials testing the same drug.

Other recruiting trials for Blood Glucose

Currently open trials in the same condition.

Other Instituto Politécnico de Bragança trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05397509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing